Immuneering Corp. Reports Q3 Loss, Highlights Progress

TipRanksNov 15 22:54 ET

Immuneering GAAP EPS of -$0.49

Seeking AlphaNov 14 10:14 ET

Express News | Immuneering Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results. Needham Reiterated a Buy Rating on the Stock

BenzingaNov 14 08:55 ET

Morgan Stanley Maintains Immuneering(IMRX.US) With Hold Rating, Maintains Target Price $4

Moomoo NewsNov 14 07:31 ET · Ratings

Cautious Hold Recommendation on Immuneering Amid Promising Developments and Financial Uncertainties

TipRanksNov 14 06:57 ET · Ratings

Needham Maintains Immuneering(IMRX.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsNov 14 05:32 ET · Ratings